EcoDrugPlus

Lysine Demethylase 1a

Ensembl ID : ENSCVAG00000014939
Gene Symbol: KDM1A
3 Cross references
214 Possible Orthologues:

Lysyl Oxidase Homolog 2a-Like

Ensembl ID : ENSCVAG00000002626
Gene Symbol: LOC107097287
3 Cross references
209 Possible Orthologues:

Lysyl Oxidase-Like 2b

Ensembl ID : ENSCVAG00000016934
Gene Symbol: LOXL2B
1 Cross references
213 Possible Orthologues:

Macrophage Colony-Stimulating Factor 1 Receptor 1-Like

Ensembl ID : ENSCVAG00000010915
Gene Symbol: LOC107095001
3 Cross references
207 Possible Orthologues:

Macrophage Colony-Stimulating Factor 1 Receptor 2-Like

Ensembl ID : ENSCVAG00000000775
Gene Symbol: LOC107102293
2 Cross references
199 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSCVAG00000020977
Gene Symbol: MIF
3 Cross references
235 Possible Orthologues:

Macrophage Stimulating 1 Receptor

Ensembl ID : ENSCVAG00000001188
Gene Symbol: MST1R
2 Cross references
194 Possible Orthologues:

Macrophage-Stimulating Protein Receptor-Like

Ensembl ID : ENSCVAG00000020562
Gene Symbol: LOC107097508
2 Cross references
196 Possible Orthologues:

Mast/stem Cell Growth Factor Receptor Kita-Like

Ensembl ID : ENSCVAG00000023436
Gene Symbol: LOC107093495
3 Cross references
207 Possible Orthologues:

Matrix Metallopeptidase 14

Ensembl ID : ENSCVAG00000007219
Gene Symbol: MMP14
3 Cross references
199 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSCVAG00000018402
Gene Symbol: MMP2
3 Cross references
210 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSCVAG00000013096
Gene Symbol: MMP9
3 Cross references
216 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).